Tumour cell-activated platelets modulate the immunological activity of CD4+, CD8+, and NK cells, which is efficiently antagonized by heparinLukas Maria Gockel(University of Bonn), Martin Schlesinger(University of Bonn)Cancer Immunology ImmunotherapyMarch 14, 202210.1007/s00262-022-03186-5Cited by 21SaveCiteExport RISWatch citationsRelated PapersDesign, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models|Archiv der Pharmazie|2022|22